IP Library Granted Patent US 12,018,320
Granted Patent B2
US 12,018,320 · App. 17/675,502 · Granted Jun 25, 2024

Selective oxidation of 5-methylcytosine by TET-family proteins

Inventors: Anjana Rao (La Jolla, CA); Mamta Tahiliani (New York, NY); Kian Peng Koh (Jamaica Plain, MA); Suneet Agarwal (Belmont, MA); Aravind Iyer (Bethesda, MD)
Assignees: The Children's Medical Center Corporation; The United States of America, As Represented by the Secretary, Department of Health & Human Services
C12Q1/6827C12N9/1007C12Q1/26C12Q1/6806C12Q1/6869G01N33/5308C12N2501/70C12N2501/71C12N2501/724C12Q2521/531C12Q2522/10C12Q2537/164C12Q2600/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,018,320
App. No.
17/675,502
Granted
Jun 25, 2024
Kind
B2
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (16)

1. A method, comprising:

(a) providing (i) a polynucleotide comprising an epigenetic modification and (ii) an enzyme or a catalytically active fragment thereof and contacting said polynucleotide with said enzyme or said catalytically active fragment thereof;

(b) oxidizing said epigenetic modification of said polynucleotide using said enzyme or said catalytically active fragment thereof to generate an oxidized epigenetic modification; and

(c) using said oxidized epigenetic modification or derivative thereof to identify said epigenetic modification of said polynucleotide.

2. The method of claim 1 , wherein, prior to (a), said polynucleotide is isolated from an extracellular fluid.

3. The method of claim 1 , wherein said epigenetic modification comprises methylation.

4. The method of claim 1 , wherein (c) comprises sequencing.

5. The method of claim 1 , wherein (c) comprises imaging said oxidized polynucleotide or derivative thereof.

6. The method of claim 1 , wherein said enzyme comprises an active ten-eleven translocation (TET) family enzyme.

7. The method of claim 6 , wherein said enzyme comprises a TET1 enzyme.

8. The method of claim 6 , wherein said enzyme comprises a TET2 enzyme.

9. The method of claim 6 , wherein said enzyme comprises a TET3 enzyme.

10. The method of claim 1 , wherein said enzyme comprises a CXXC4 enzyme.

11. The method of claim 1 , wherein said oxidized epigenetic modification is generated by more than one oxidation reaction.

12. The method of claim 1 , further comprising, during or subsequent to (b), contacting said epigenetic modification with a glucosyltransferase to generate a glycosylated oxidized epigenetic modification.

13. The method of claim 12 , wherein said glucosyltransferase comprises beta-glucosyltransferase or alpha-glucosyltransferase.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2024
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 066113/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2024
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 066113/0873 →
MERGER Recorded Jan 12, 2024
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 066113/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2024
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 066113/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2024
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 066113/0909 →
Continuity (11)
Continuation 17350181 · Jun 17, 2021
Continuation 16380846 · Apr 10, 2019
Continuation 15440815 · Feb 23, 2017
Continuation 15341344 · Nov 2, 2016
Continuation 15193796 · Jun 27, 2016
Continuation 13795739 · Mar 12, 2013
Continuation 13120861
Provisional Application 61121844 · Dec 11, 2008
Provisional Application 61100995 · Sep 29, 2008
Provisional Application 61100503 · Sep 26, 2008
Related Publication 20220348995A1 · Nov 3, 2022
Cited By (3)
US 12,338,489 US 12,467,082 US 12,630,866